PEAK6 Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$4.29M Buy
197,400
+171,300
+656% +$3.35M 0.02% 856
2018
Q1
$461K Sell
26,100
-400
-2% -$7.05K ﹤0.01% 2641
2017
Q4
$497K Sell
26,500
-21,300
-45% -$424K ﹤0.01% 2478
2017
Q3
$1.05M Buy
47,800
+37,400
+360% +$845K 0.01% 1923
2017
Q2
$251K Buy
10,400
+5,300
+104% +$135K ﹤0.01% 3161
2017
Q1
$142K Sell
5,100
-6,100
-54% -$160K ﹤0.01% 3352
2016
Q4
$274K Buy
11,200
+600
+6% +$13.8K ﹤0.01% 3066
2016
Q3
$267K Sell
10,600
-8,600
-45% -$206K ﹤0.01% 2910
2016
Q2
$396K Buy
+19,200
New +$400K ﹤0.01% 2575

Other funds holding SBRA

PEAK6 Group's SBRA Position: Q3 2017 in Review

PEAK6 Group sold out of Sabra Healthcare REIT (SBRA) in Q3 2017, closing a stake of 2,588 shares — an estimated $58.5K sold.

PEAK6 Group first reported a position in SBRA in Q2 2017 and held it in 1 quarter. The position peaked at $62K in Q2 2017. 337 funds tracked by Wall St. Rank hold SBRA as of Q3 2017.

  • PEAK6 Group reported no remaining Sabra Healthcare REIT position as of Q3 2017 after selling out during the quarter.
  • PEAK6 Group sold 2,588 Sabra Healthcare REIT shares in Q3 2017, an estimated $58.5K.
  • PEAK6 Group first reported a position in Sabra Healthcare REIT in Q2 2017 and held it in 1 quarter.
  • PEAK6 Group's Sabra Healthcare REIT position peaked at $62K in Q2 2017.
  • 337 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2017.

Based on PEAK6 Group's 13F filing for Q3 2017, filed 14 Nov 2017.